Pharmaceutical and biotech companies are spending years and millions of dollars developing drugs or promising new biologics, all with the hopes of saving or enhancing patients’ lives. This specialization will provide you with a 30,000 feet view of the entire process of drug discovery and development. In the first course you will begin with learning how scientists go from selecting a drug discovery target to filing an Initial New Drug application. In the second course you will learn the intricacy of drug development from Phase 0 to Phase 3 clinical trials and filing a New Drug Application. Finally, in the third course, the specialization will provide you an understanding of the complexities in launching new pharmaceutical products, ensuring sales success and patient access. Healthcare in the U.S. is unlike any other developed country, and this third course provides a good overview for anyone wanting to understand how the U.S. market works.
By the end of the specialization, you will have mastered a better understanding of the process of discovering new drugs. After completing this specialization if you are interested in pursuing a career specializing in drug development and product management you may want to consider exploring our Master of Science in Drug Development & Product Management at ddpm.ucsd.edu
Overview
Syllabus
Course 1: Drug Discovery
- Offered by University of California San Diego. The University of California San Diego, Skaggs School of Pharmacy and Pharmaceutical Sciences ... Enroll for free.
Course 2: Drug Development
- Offered by University of California San Diego. The University of California San Diego, Skaggs School of Pharmacy and Pharmaceutical Sciences ... Enroll for free.
Course 3: Drug Commercialization
- Offered by University of California San Diego. The University of California San Diego, Skaggs School of Pharmacy and Pharmaceutical Sciences ... Enroll for free.
- Offered by University of California San Diego. The University of California San Diego, Skaggs School of Pharmacy and Pharmaceutical Sciences ... Enroll for free.
Course 2: Drug Development
- Offered by University of California San Diego. The University of California San Diego, Skaggs School of Pharmacy and Pharmaceutical Sciences ... Enroll for free.
Course 3: Drug Commercialization
- Offered by University of California San Diego. The University of California San Diego, Skaggs School of Pharmacy and Pharmaceutical Sciences ... Enroll for free.
Courses
-
The University of California San Diego, Skaggs School of Pharmacy and Pharmaceutical Sciences Drug Discovery course brings you lectures from both faculty and industry experts. With this course, recorded on campus at UCSD, we seek to share our access to top people in the field who bring an unprecedented range of expertise on drug discovery. In this course you will learn the drug discovery process up to the filing of an Initial New Drug Application or IND. Each week you will learn the steps that a pharmaceutical or biotech company goes through to discover a new therapeutic drug. In this course you will be able to: * Understand the pharmaceutical and biotechnology market a changing landscape * Learn the major aspects of the drug discovery process, starting with target selection, to compound screening to designing lead candidates. * Recognize current modern drug discovery based on the lock-and-key theory, which attempts to use one single compound to hit one target to combat the related disease. * Increase understanding of the various drug discovery tools and methods that are used for finding, identifying and designing a new drug. * Define and understand the regulatory responsibilities for drug discovery to file an Investigational New Drug Application (IND). This course is intended as part 1 of a series: Drug Discovery, Drug Development (https://www.coursera.org/learn/drug-development) and Drug Commercialization (https://www.coursera.org/learn/drug-commercialization). We would highly recommend that you take the courses in order since it will give you a better understanding on how a drug is discovered in the lab before being tested in clinical trials and then launched in the market place.
-
The University of California San Diego, Skaggs School of Pharmacy and Pharmaceutical Sciences Drug Development course brings you lectures from both faculty and industry experts. With this course, recorded on campus at UCSD, we seek to share our access to top people in the field who bring an unprecedented range of expertise on drug development. In this course you will learn the different stages of clinical development as well as the regulatory including but not limited to, an Investigational New Drug Application (IND), New Drug Application (NDA), and product labeling. Additionally you will learn how to Incorporate study design methods for consideration in the design of clinical protocols to assess safety, tolerability, and efficacy in multiple therapeutic areas. In this course you will learn the different phases of clinical development: * Phase 1 or early stage clinical trial are conducted primarÂily to determine how the new drug works in humans, its safety profile and to predict its dosage range. It typically involves between 30 and 100 healthy volunteers. * Phase 2 or Proof of Concept POC studies test for efficacy as well as safety and side effects in a group of between 30 to 200 hundred patients with the disease for which the new drug is being developed. * Phase 3 or late stage clinical development involve much larger group of patients, between a few hundred to thousands, depending on the indication, which will help determine if the new drug can be considered both safe and effective. It will involve control groups using placebo and/or current treatment as a comparison. * Product registration and approval process after a drug is considered safe and effective from Phase 3 trials, it must be authorized in each individual country before it can be marketed. All data genÂerated about the small molecule or biologic is collected and submitted to the regulatory authorities in the US at the FDA, Food and Drug Administration FDA, in Europe the EMA or European Medicines Agency, Japan Ministry of Health and other countries which may require their own national approvals. This course is intended as part 2 of a series: Drug Discovery (https://www.coursera.org/learn/drug-discovery), Drug Development and Drug Commercialization (https://www.coursera.org/learn/drug-commercialization). We would highly recommend that you take the courses in order since it will give you a better understanding on how a drug is discovered in the lab before being tested in clinical trials and then launched in the market place.
-
The University of California San Diego, Skaggs School of Pharmacy and Pharmaceutical Sciences Drug Commercialization course brings you lectures from both faculty and industry experts. With this course, recorded on campus at UCSD, we seek to share our access to top people in the field who bring an unprecedented range of expertise on drug commercialization. This course will cover pharmacoeconomic, marketing strategy, intellectual property strategy, portfolio management, managed markets and strategic alliances. It will also have a lecture case study from startup to success. In addition, the course will discuss post-marketing clinical trials or Phase 4 trials. These are conducted after a new drug has been approved by the regulatory agencies and launched. In these studies, the new drug is prescribed in an everyday healthcare environÂment using a much larger group of patients. This enables new treatÂment uses for the new drug to be developed, comparisons with other treatments for the same indication to be made, and determination of the clinical effectiveness of the new drug in a wider variety of patient types, and more rare side effects, if any, may be detected . Pre-marketing strategy should be instigated as early as Phase 1 clinical trials to ensure that the market's needs are incorporated into the new drug's overall developÂment. Later phases when clinical results are presented at international medical conferences the marketing strategy is then refined in order to develop an awareness amongst the medical community who will be prescribing the new drug. In addition to the marketing strategy, pricing strategy and a tactical plan will be developed. Promotional material, and the sales force will be trained so that when the product is approved they can promote the drug to physician, pharmacist and nurses. This course is intended as part 3 of a series: Drug Discovery (https://www.coursera.org/learn/drug-discovery), Drug Development (https://www.coursera.org/learn/drug-development) and Drug Commercialization. We would highly recommend that you take the courses in order since it will give you a better understanding on how a drug is discovered in the lab before being tested in clinical trials and then launched in the market place.
Taught by
Joseph D. Ma and Williams S. Ettouati, Pharm.D.
Related Courses
Related articles
Reviews
4.0 rating, based on 1 Class Central review
-
This Coursera Specialization is an excellent introduction to the typical iteration component processes of pharmaceutical endeavors (which include not only the pharmaceutical industry in the conventional sense). For the uninitiated but deeply interested in the field like me, the material is extremely useful for understanding such endeavors at a level of detail that seems sufficient to make career-related decisions. Unfortunately, as of this writing, the material in all courses of this Specialization is outdated by at least half a decade, and I hope that the course instructors strongly consider updating the contents as soon as possible.
